SEC Comment Letter for Wave Life Sciences, Inc. (WVE) (CIK 0001631574) (WVE) — Aug 9, 2019
Wave Life Sciences, Inc. (WVE) (CIK 0001631574)
Date: Aug. 9, 2019 · CIK: 0001631574 · Accession: 0000000000-19-012261
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-233052
Letter
August 9, 2019 Paul Bolno Chief Executive Officer Wave Life Sciences Ltd. 7 Straits View #12-00, Marina One East Tower Singapore 018936 Re:Wave Life Sciences Ltd. Registration Statement on Form S-3 Filed August 6, 2019 File No. 333-233052 Dear Dr. Bolno: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tonya K. Aldave at (202) 551-3601 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: John Condon, Esq.
Show Raw Text
August 9, 2019
Paul Bolno
Chief Executive Officer
Wave Life Sciences Ltd.
7 Straits View #12-00, Marina One East Tower
Singapore 018936
Re:Wave Life Sciences Ltd.
Registration Statement on Form S-3
Filed August 6, 2019
File No. 333-233052
Dear Dr. Bolno:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tonya K. Aldave at (202) 551-3601 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: John Condon, Esq.